Research and bioproduction

Targeting precision and simplicity of use are two major assets in the industrial applications of Cellectis’ technology.

Meganucleases have many potential applications as research tools, particularly for studies of gene function. Commercial prospects in this field are more limited, but the widespread use of the Company’s innovative technology in this field could lead to its being adopted as the global standard for rational and precise Genome modification.

Research kits are marketed and sold by the subsidiary Cellectis bioresearch. They carry out targeted integration of a gene into various cell lines using natural or modified meganucleases. Standard terms and conditions are supplied for use solely in research. For all other applications, for example the production of therapeutic proteins and antibodies, screening or profiling of active molecules, a commercial license is required.

In the field of therapeutic Protein production, Meganucleases applications have unique competitive advantages in terms of production processes, decreases in cycle time and improvements in therapeutic Protein quality. The specificity of Meganucleases ensures the safe and reliable targeting of active Genome sequences. Meganucleases are also very simple to use in the development of manufacturing processes.